12.10.20 -- Bioprocessing Year In Review: 11 Key Trends Accelerated By COVID-19
Nanoform Finland Plc (Nanoform), an innovative nanoparticle medicine enabling company, will be featured in an upcoming Advancements episode broadcasting via CNBC on Saturday, December 12, at 2:30 p.m. (ET). Viewers will learn how Nanoform’s award-winning CESS® nanoparticle engineering technology can potentially double the number of drug candidates progressing into clinic. Featured Editorial By Ronald A. Rader and Eric S. Langer, BioPlan Associates, Inc. Despite the morbidity, deaths, and terrible societal disruptions associated with the COVID-19 pandemic, 2020 will have created something of a positive outcome for the bioprocessing sector. By James Akers, James Agalloco, and Russell Madsen